Approach
Team
News
Contact
Author Archives:
Gabriel Silverman
Picking A PCSK9
Liphorus Pharmaceuticals announces financing of $6.4 million to support development of small molecules inhibitors targeting PCSK9 for the treatment of hypercholesterolemia
Creation of Liphorus Pharmaceuticals A significant investment in healthcare in Montréal